Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Debt Ratio (2022 - 2025)

Historic Debt Ratio for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 0.24.

  • Centessa Pharmaceuticals' Debt Ratio rose 9730.04% to 0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24, marking a year-over-year increase of 9730.04%. This contributed to the annual value of 0.19 for FY2024, which is 1011.92% down from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Debt Ratio stood at 0.24 for Q3 2025, which was up 9730.04% from 0.22 recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Debt Ratio high stood at 0.24 for Q3 2025, and its period low was 0.12 during Q3 2024.
  • Its 4-year average for Debt Ratio is 0.18, with a median of 0.19 in 2024.
  • Its Debt Ratio has fluctuated over the past 5 years, first tumbled by 3668.63% in 2024, then soared by 9730.04% in 2025.
  • Quarter analysis of 4 years shows Centessa Pharmaceuticals' Debt Ratio stood at 0.16 in 2022, then soared by 33.76% to 0.21 in 2023, then fell by 10.12% to 0.19 in 2024, then increased by 29.7% to 0.24 in 2025.
  • Its Debt Ratio stands at 0.24 for Q3 2025, versus 0.22 for Q2 2025 and 0.21 for Q1 2025.